nodes	percent_of_prediction	percent_of_DWPC	metapath
Paroxetine—TACR1—asthma	0.357	1	CbGaD
Paroxetine—CHRM5—Ipratropium bromide—asthma	0.0377	0.0988	CbGbCtD
Paroxetine—CHRM5—Tiotropium—asthma	0.0286	0.0748	CbGbCtD
Paroxetine—CHRM3—Ipratropium bromide—asthma	0.0241	0.0631	CbGbCtD
Paroxetine—CHRM1—Ipratropium bromide—asthma	0.021	0.0549	CbGbCtD
Paroxetine—CHRM2—Ipratropium bromide—asthma	0.0193	0.0506	CbGbCtD
Paroxetine—CHRM3—Tiotropium—asthma	0.0183	0.0478	CbGbCtD
Paroxetine—CHRM1—Tiotropium—asthma	0.0159	0.0416	CbGbCtD
Paroxetine—CHRM2—Tiotropium—asthma	0.0146	0.0384	CbGbCtD
Paroxetine—CYP2C8—Mometasone—asthma	0.0124	0.0325	CbGbCtD
Paroxetine—CYP2C8—Salmeterol—asthma	0.0124	0.0325	CbGbCtD
Paroxetine—ABCB1—Fluticasone furoate—asthma	0.0111	0.029	CbGbCtD
Paroxetine—CYP2C8—Zafirlukast—asthma	0.00973	0.0255	CbGbCtD
Paroxetine—ABCB1—Indacaterol—asthma	0.00902	0.0236	CbGbCtD
Paroxetine—CYP2D6—Ciclesonide—asthma	0.0085	0.0223	CbGbCtD
Paroxetine—CYP2C9—Zileuton—asthma	0.00771	0.0202	CbGbCtD
Paroxetine—CYP2C8—Theophylline—asthma	0.00751	0.0197	CbGbCtD
Paroxetine—CYP2C8—Loratadine—asthma	0.00712	0.0186	CbGbCtD
Paroxetine—CYP2C8—Montelukast—asthma	0.00712	0.0186	CbGbCtD
Paroxetine—CYP2D6—Ipratropium bromide—asthma	0.00705	0.0185	CbGbCtD
Paroxetine—TACR1—vagus nerve—asthma	0.00701	0.251	CbGeAlD
Paroxetine—CYP2C9—Zafirlukast—asthma	0.00678	0.0178	CbGbCtD
Paroxetine—CYP2C9—Arformoterol—asthma	0.00655	0.0172	CbGbCtD
Paroxetine—CYP2C9—Formoterol—asthma	0.00655	0.0172	CbGbCtD
Paroxetine—CYP2D6—Zafirlukast—asthma	0.0062	0.0162	CbGbCtD
Paroxetine—CYP2D6—Formoterol—asthma	0.00599	0.0157	CbGbCtD
Paroxetine—CYP2D6—Arformoterol—asthma	0.00599	0.0157	CbGbCtD
Paroxetine—CYP2D6—Tiotropium—asthma	0.00534	0.014	CbGbCtD
Paroxetine—CYP2C9—Theophylline—asthma	0.00524	0.0137	CbGbCtD
Paroxetine—CYP2C9—Montelukast—asthma	0.00497	0.013	CbGbCtD
Paroxetine—CYP2C9—Loratadine—asthma	0.00497	0.013	CbGbCtD
Paroxetine—ABCB1—Loratadine—asthma	0.00482	0.0126	CbGbCtD
Paroxetine—CYP2D6—Theophylline—asthma	0.00479	0.0125	CbGbCtD
Paroxetine—CYP2D6—Loratadine—asthma	0.00454	0.0119	CbGbCtD
Paroxetine—ABCB1—Methylprednisolone—asthma	0.00441	0.0115	CbGbCtD
Paroxetine—CYP2C8—Hydrocortisone—asthma	0.00396	0.0104	CbGbCtD
Paroxetine—CYP2B6—Dexamethasone—asthma	0.00325	0.00852	CbGbCtD
Paroxetine—ABCB1—Betamethasone—asthma	0.00287	0.00751	CbGbCtD
Paroxetine—ABCB1—Prednisolone—asthma	0.00283	0.00741	CbGbCtD
Paroxetine—ABCB1—Hydrocortisone—asthma	0.00268	0.00702	CbGbCtD
Paroxetine—ABCB1—Prednisone—asthma	0.00267	0.00699	CbGbCtD
Paroxetine—CYP2C8—Dexamethasone—asthma	0.00246	0.00645	CbGbCtD
Paroxetine—SLC6A2—autonomic nervous system—asthma	0.00197	0.0707	CbGeAlD
Paroxetine—CYP2C9—Dexamethasone—asthma	0.00172	0.0045	CbGbCtD
Paroxetine—HTR2A—vagus nerve—asthma	0.00171	0.0612	CbGeAlD
Paroxetine—ABCB1—Dexamethasone—asthma	0.00167	0.00437	CbGbCtD
Paroxetine—CYP2D6—Dexamethasone—asthma	0.00157	0.00411	CbGbCtD
Paroxetine—TACR1—respiratory system—asthma	0.00125	0.0448	CbGeAlD
Paroxetine—HTR2A—autonomic nervous system—asthma	0.00119	0.0425	CbGeAlD
Paroxetine—TACR1—smooth muscle tissue—asthma	0.00101	0.0361	CbGeAlD
Paroxetine—CHRM3—exocrine gland—asthma	0.000988	0.0354	CbGeAlD
Paroxetine—TACR1—trachea—asthma	0.000925	0.0331	CbGeAlD
Paroxetine—CHRM5—epithelium—asthma	0.000769	0.0275	CbGeAlD
Paroxetine—TACR1—adrenal gland—asthma	0.000758	0.0272	CbGeAlD
Paroxetine—TACR1—lung—asthma	0.000664	0.0238	CbGeAlD
Paroxetine—SLC6A3—respiratory system—asthma	0.000629	0.0226	CbGeAlD
Paroxetine—SLC6A4—respiratory system—asthma	0.000577	0.0207	CbGeAlD
Paroxetine—SLC6A2—respiratory system—asthma	0.000508	0.0182	CbGeAlD
Paroxetine—CHRM2—cardiovascular system—asthma	0.000483	0.0173	CbGeAlD
Paroxetine—CHRM1—cardiovascular system—asthma	0.00044	0.0158	CbGeAlD
Paroxetine—CHRM1—trachea—asthma	0.000425	0.0152	CbGeAlD
Paroxetine—CHRM3—smooth muscle tissue—asthma	0.000414	0.0148	CbGeAlD
Paroxetine—CYP2B6—respiratory system—asthma	0.000374	0.0134	CbGeAlD
Paroxetine—SLC6A3—lung—asthma	0.000334	0.012	CbGeAlD
Paroxetine—CYP2B6—adrenal cortex—asthma	0.000314	0.0113	CbGeAlD
Paroxetine—CYP2B6—bronchus—asthma	0.000308	0.011	CbGeAlD
Paroxetine—SLC6A2—adrenal gland—asthma	0.000308	0.011	CbGeAlD
Paroxetine—SLC6A4—lung—asthma	0.000306	0.011	CbGeAlD
Paroxetine—HTR2A—respiratory system—asthma	0.000305	0.0109	CbGeAlD
Paroxetine—CHRM1—lung—asthma	0.000305	0.0109	CbGeAlD
Paroxetine—CYP2B6—cardiovascular system—asthma	0.000287	0.0103	CbGeAlD
Paroxetine—CYP2C9—cardiovascular system—asthma	0.000284	0.0102	CbGeAlD
Paroxetine—SLC6A2—lung—asthma	0.00027	0.00966	CbGeAlD
Paroxetine—HTR2A—epithelium—asthma	0.000255	0.00914	CbGeAlD
Paroxetine—HTR2A—smooth muscle tissue—asthma	0.000246	0.00881	CbGeAlD
Paroxetine—HTR2A—cardiovascular system—asthma	0.000234	0.00838	CbGeAlD
Paroxetine—CYP2B6—adrenal gland—asthma	0.000227	0.00812	CbGeAlD
Paroxetine—HTR2A—trachea—asthma	0.000226	0.00808	CbGeAlD
Paroxetine—ABCB1—respiratory system—asthma	0.0002	0.00717	CbGeAlD
Paroxetine—CYP2B6—lung—asthma	0.000199	0.00712	CbGeAlD
Paroxetine—HTR2A—adrenal gland—asthma	0.000185	0.00663	CbGeAlD
Paroxetine—ABCB1—adrenal cortex—asthma	0.000168	0.00601	CbGeAlD
Paroxetine—ABCB1—epithelium—asthma	0.000167	0.00599	CbGeAlD
Paroxetine—HTR2A—lung—asthma	0.000162	0.00581	CbGeAlD
Paroxetine—ABCB1—cardiovascular system—asthma	0.000153	0.00549	CbGeAlD
Paroxetine—ABCB1—trachea—asthma	0.000148	0.0053	CbGeAlD
Paroxetine—ABCB1—adrenal gland—asthma	0.000121	0.00434	CbGeAlD
Paroxetine—ABCB1—lung—asthma	0.000106	0.00381	CbGeAlD
Paroxetine—Cough—Triamcinolone—asthma	1.43e-05	9.07e-05	CcSEcCtD
Paroxetine—Anaphylactic shock—Hydrocortisone—asthma	1.42e-05	9.01e-05	CcSEcCtD
Paroxetine—Oedema—Hydrocortisone—asthma	1.42e-05	9.01e-05	CcSEcCtD
Paroxetine—Convulsion—Triamcinolone—asthma	1.41e-05	9e-05	CcSEcCtD
Paroxetine—Tachycardia—Prednisolone—asthma	1.41e-05	9e-05	CcSEcCtD
Paroxetine—Convulsion—Methylprednisolone—asthma	1.41e-05	8.98e-05	CcSEcCtD
Paroxetine—Hypertension—Triamcinolone—asthma	1.41e-05	8.97e-05	CcSEcCtD
Paroxetine—Hypertension—Methylprednisolone—asthma	1.41e-05	8.95e-05	CcSEcCtD
Paroxetine—Infection—Hydrocortisone—asthma	1.41e-05	8.95e-05	CcSEcCtD
Paroxetine—Hyperhidrosis—Prednisolone—asthma	1.4e-05	8.91e-05	CcSEcCtD
Paroxetine—Shock—Hydrocortisone—asthma	1.39e-05	8.86e-05	CcSEcCtD
Paroxetine—Myalgia—Triamcinolone—asthma	1.39e-05	8.85e-05	CcSEcCtD
Paroxetine—Nervous system disorder—Hydrocortisone—asthma	1.39e-05	8.83e-05	CcSEcCtD
Paroxetine—Myalgia—Methylprednisolone—asthma	1.39e-05	8.83e-05	CcSEcCtD
Paroxetine—Arthralgia—Methylprednisolone—asthma	1.39e-05	8.83e-05	CcSEcCtD
Paroxetine—Eye disorder—Prednisone—asthma	1.39e-05	8.81e-05	CcSEcCtD
Paroxetine—Anxiety—Methylprednisolone—asthma	1.38e-05	8.8e-05	CcSEcCtD
Paroxetine—Tachycardia—Hydrocortisone—asthma	1.38e-05	8.79e-05	CcSEcCtD
Paroxetine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—asthma	1.38e-05	8.77e-05	CcSEcCtD
Paroxetine—Flushing—Prednisone—asthma	1.38e-05	8.75e-05	CcSEcCtD
Paroxetine—Skin disorder—Hydrocortisone—asthma	1.37e-05	8.75e-05	CcSEcCtD
Paroxetine—Ill-defined disorder—Betamethasone—asthma	1.37e-05	8.75e-05	CcSEcCtD
Paroxetine—Ill-defined disorder—Dexamethasone—asthma	1.37e-05	8.75e-05	CcSEcCtD
Paroxetine—Discomfort—Triamcinolone—asthma	1.37e-05	8.74e-05	CcSEcCtD
Paroxetine—Discomfort—Methylprednisolone—asthma	1.37e-05	8.72e-05	CcSEcCtD
Paroxetine—Hyperhidrosis—Hydrocortisone—asthma	1.37e-05	8.71e-05	CcSEcCtD
Paroxetine—Dry mouth—Triamcinolone—asthma	1.36e-05	8.65e-05	CcSEcCtD
Paroxetine—Angioedema—Betamethasone—asthma	1.35e-05	8.61e-05	CcSEcCtD
Paroxetine—Angioedema—Dexamethasone—asthma	1.35e-05	8.61e-05	CcSEcCtD
Paroxetine—Angiopathy—Prednisone—asthma	1.34e-05	8.56e-05	CcSEcCtD
Paroxetine—Confusional state—Methylprednisolone—asthma	1.34e-05	8.53e-05	CcSEcCtD
Paroxetine—Immune system disorder—Prednisone—asthma	1.34e-05	8.52e-05	CcSEcCtD
Paroxetine—Malaise—Dexamethasone—asthma	1.34e-05	8.5e-05	CcSEcCtD
Paroxetine—Malaise—Betamethasone—asthma	1.34e-05	8.5e-05	CcSEcCtD
Paroxetine—Anaphylactic shock—Triamcinolone—asthma	1.33e-05	8.48e-05	CcSEcCtD
Paroxetine—Oedema—Triamcinolone—asthma	1.33e-05	8.48e-05	CcSEcCtD
Paroxetine—Vertigo—Dexamethasone—asthma	1.33e-05	8.47e-05	CcSEcCtD
Paroxetine—Vertigo—Betamethasone—asthma	1.33e-05	8.47e-05	CcSEcCtD
Paroxetine—Anaphylactic shock—Methylprednisolone—asthma	1.33e-05	8.46e-05	CcSEcCtD
Paroxetine—Syncope—Dexamethasone—asthma	1.33e-05	8.46e-05	CcSEcCtD
Paroxetine—Syncope—Betamethasone—asthma	1.33e-05	8.46e-05	CcSEcCtD
Paroxetine—Arrhythmia—Prednisone—asthma	1.32e-05	8.43e-05	CcSEcCtD
Paroxetine—Infection—Triamcinolone—asthma	1.32e-05	8.43e-05	CcSEcCtD
Paroxetine—Hypotension—Hydrocortisone—asthma	1.32e-05	8.42e-05	CcSEcCtD
Paroxetine—Infection—Methylprednisolone—asthma	1.32e-05	8.41e-05	CcSEcCtD
Paroxetine—Shock—Triamcinolone—asthma	1.31e-05	8.34e-05	CcSEcCtD
Paroxetine—Insomnia—Prednisolone—asthma	1.31e-05	8.34e-05	CcSEcCtD
Paroxetine—Alopecia—Prednisone—asthma	1.31e-05	8.33e-05	CcSEcCtD
Paroxetine—Shock—Methylprednisolone—asthma	1.31e-05	8.32e-05	CcSEcCtD
Paroxetine—Nervous system disorder—Methylprednisolone—asthma	1.3e-05	8.3e-05	CcSEcCtD
Paroxetine—Loss of consciousness—Dexamethasone—asthma	1.3e-05	8.29e-05	CcSEcCtD
Paroxetine—Loss of consciousness—Betamethasone—asthma	1.3e-05	8.29e-05	CcSEcCtD
Paroxetine—Paraesthesia—Prednisolone—asthma	1.3e-05	8.28e-05	CcSEcCtD
Paroxetine—Tachycardia—Triamcinolone—asthma	1.3e-05	8.28e-05	CcSEcCtD
Paroxetine—Mental disorder—Prednisone—asthma	1.3e-05	8.26e-05	CcSEcCtD
Paroxetine—Tachycardia—Methylprednisolone—asthma	1.3e-05	8.26e-05	CcSEcCtD
Paroxetine—Skin disorder—Methylprednisolone—asthma	1.29e-05	8.22e-05	CcSEcCtD
Paroxetine—Erythema—Prednisone—asthma	1.29e-05	8.21e-05	CcSEcCtD
Paroxetine—Malnutrition—Prednisone—asthma	1.29e-05	8.21e-05	CcSEcCtD
Paroxetine—Musculoskeletal discomfort—Hydrocortisone—asthma	1.29e-05	8.21e-05	CcSEcCtD
Paroxetine—Hyperhidrosis—Triamcinolone—asthma	1.29e-05	8.2e-05	CcSEcCtD
Paroxetine—Hyperhidrosis—Methylprednisolone—asthma	1.29e-05	8.18e-05	CcSEcCtD
Paroxetine—Convulsion—Betamethasone—asthma	1.28e-05	8.17e-05	CcSEcCtD
Paroxetine—Convulsion—Dexamethasone—asthma	1.28e-05	8.17e-05	CcSEcCtD
Paroxetine—Insomnia—Hydrocortisone—asthma	1.28e-05	8.15e-05	CcSEcCtD
Paroxetine—Hypertension—Betamethasone—asthma	1.28e-05	8.14e-05	CcSEcCtD
Paroxetine—Hypertension—Dexamethasone—asthma	1.28e-05	8.14e-05	CcSEcCtD
Paroxetine—Paraesthesia—Hydrocortisone—asthma	1.27e-05	8.09e-05	CcSEcCtD
Paroxetine—Myalgia—Betamethasone—asthma	1.26e-05	8.03e-05	CcSEcCtD
Paroxetine—Myalgia—Dexamethasone—asthma	1.26e-05	8.03e-05	CcSEcCtD
Paroxetine—Anxiety—Betamethasone—asthma	1.26e-05	8e-05	CcSEcCtD
Paroxetine—Anxiety—Dexamethasone—asthma	1.26e-05	8e-05	CcSEcCtD
Paroxetine—Discomfort—Betamethasone—asthma	1.25e-05	7.93e-05	CcSEcCtD
Paroxetine—Discomfort—Dexamethasone—asthma	1.25e-05	7.93e-05	CcSEcCtD
Paroxetine—Dyspepsia—Hydrocortisone—asthma	1.25e-05	7.93e-05	CcSEcCtD
Paroxetine—Hypotension—Methylprednisolone—asthma	1.24e-05	7.91e-05	CcSEcCtD
Paroxetine—Pain—Prednisolone—asthma	1.24e-05	7.89e-05	CcSEcCtD
Paroxetine—Decreased appetite—Hydrocortisone—asthma	1.23e-05	7.83e-05	CcSEcCtD
Paroxetine—Gastrointestinal disorder—Hydrocortisone—asthma	1.22e-05	7.78e-05	CcSEcCtD
Paroxetine—Fatigue—Hydrocortisone—asthma	1.22e-05	7.76e-05	CcSEcCtD
Paroxetine—Vision blurred—Prednisone—asthma	1.22e-05	7.74e-05	CcSEcCtD
Paroxetine—Musculoskeletal discomfort—Triamcinolone—asthma	1.21e-05	7.73e-05	CcSEcCtD
Paroxetine—Musculoskeletal discomfort—Methylprednisolone—asthma	1.21e-05	7.71e-05	CcSEcCtD
Paroxetine—Pain—Hydrocortisone—asthma	1.21e-05	7.7e-05	CcSEcCtD
Paroxetine—Oedema—Betamethasone—asthma	1.21e-05	7.69e-05	CcSEcCtD
Paroxetine—Anaphylactic shock—Betamethasone—asthma	1.21e-05	7.69e-05	CcSEcCtD
Paroxetine—Anaphylactic shock—Dexamethasone—asthma	1.21e-05	7.69e-05	CcSEcCtD
Paroxetine—Oedema—Dexamethasone—asthma	1.21e-05	7.69e-05	CcSEcCtD
Paroxetine—Insomnia—Triamcinolone—asthma	1.21e-05	7.67e-05	CcSEcCtD
Paroxetine—Insomnia—Methylprednisolone—asthma	1.2e-05	7.65e-05	CcSEcCtD
Paroxetine—Infection—Dexamethasone—asthma	1.2e-05	7.64e-05	CcSEcCtD
Paroxetine—Infection—Betamethasone—asthma	1.2e-05	7.64e-05	CcSEcCtD
Paroxetine—Ill-defined disorder—Prednisone—asthma	1.2e-05	7.62e-05	CcSEcCtD
Paroxetine—Paraesthesia—Triamcinolone—asthma	1.2e-05	7.61e-05	CcSEcCtD
Paroxetine—Feeling abnormal—Prednisolone—asthma	1.19e-05	7.6e-05	CcSEcCtD
Paroxetine—Paraesthesia—Methylprednisolone—asthma	1.19e-05	7.6e-05	CcSEcCtD
Paroxetine—Anaemia—Prednisone—asthma	1.19e-05	7.59e-05	CcSEcCtD
Paroxetine—Shock—Betamethasone—asthma	1.19e-05	7.57e-05	CcSEcCtD
Paroxetine—Shock—Dexamethasone—asthma	1.19e-05	7.57e-05	CcSEcCtD
Paroxetine—Dyspnoea—Triamcinolone—asthma	1.19e-05	7.56e-05	CcSEcCtD
Paroxetine—Nervous system disorder—Dexamethasone—asthma	1.19e-05	7.55e-05	CcSEcCtD
Paroxetine—Nervous system disorder—Betamethasone—asthma	1.19e-05	7.55e-05	CcSEcCtD
Paroxetine—Agitation—Prednisone—asthma	1.19e-05	7.55e-05	CcSEcCtD
Paroxetine—Thrombocytopenia—Dexamethasone—asthma	1.18e-05	7.53e-05	CcSEcCtD
Paroxetine—Thrombocytopenia—Betamethasone—asthma	1.18e-05	7.53e-05	CcSEcCtD
Paroxetine—Tachycardia—Dexamethasone—asthma	1.18e-05	7.51e-05	CcSEcCtD
Paroxetine—Tachycardia—Betamethasone—asthma	1.18e-05	7.51e-05	CcSEcCtD
Paroxetine—Angioedema—Prednisone—asthma	1.18e-05	7.5e-05	CcSEcCtD
Paroxetine—Dyspepsia—Triamcinolone—asthma	1.17e-05	7.46e-05	CcSEcCtD
Paroxetine—Dyspepsia—Methylprednisolone—asthma	1.17e-05	7.45e-05	CcSEcCtD
Paroxetine—Hyperhidrosis—Dexamethasone—asthma	1.17e-05	7.44e-05	CcSEcCtD
Paroxetine—Hyperhidrosis—Betamethasone—asthma	1.17e-05	7.44e-05	CcSEcCtD
Paroxetine—Feeling abnormal—Hydrocortisone—asthma	1.17e-05	7.42e-05	CcSEcCtD
Paroxetine—Malaise—Prednisone—asthma	1.16e-05	7.4e-05	CcSEcCtD
Paroxetine—Vertigo—Prednisone—asthma	1.16e-05	7.38e-05	CcSEcCtD
Paroxetine—Gastrointestinal pain—Hydrocortisone—asthma	1.16e-05	7.36e-05	CcSEcCtD
Paroxetine—Syncope—Prednisone—asthma	1.16e-05	7.36e-05	CcSEcCtD
Paroxetine—Urticaria—Prednisolone—asthma	1.15e-05	7.33e-05	CcSEcCtD
Paroxetine—Fatigue—Triamcinolone—asthma	1.15e-05	7.31e-05	CcSEcCtD
Paroxetine—Fatigue—Methylprednisolone—asthma	1.15e-05	7.3e-05	CcSEcCtD
Paroxetine—Pain—Triamcinolone—asthma	1.14e-05	7.25e-05	CcSEcCtD
Paroxetine—Loss of consciousness—Prednisone—asthma	1.13e-05	7.22e-05	CcSEcCtD
Paroxetine—Hypotension—Betamethasone—asthma	1.13e-05	7.19e-05	CcSEcCtD
Paroxetine—Hypotension—Dexamethasone—asthma	1.13e-05	7.19e-05	CcSEcCtD
Paroxetine—Urticaria—Hydrocortisone—asthma	1.12e-05	7.15e-05	CcSEcCtD
Paroxetine—Abdominal pain—Hydrocortisone—asthma	1.12e-05	7.12e-05	CcSEcCtD
Paroxetine—Body temperature increased—Hydrocortisone—asthma	1.12e-05	7.12e-05	CcSEcCtD
Paroxetine—Convulsion—Prednisone—asthma	1.12e-05	7.11e-05	CcSEcCtD
Paroxetine—Hypertension—Prednisone—asthma	1.11e-05	7.09e-05	CcSEcCtD
Paroxetine—Musculoskeletal discomfort—Dexamethasone—asthma	1.1e-05	7.01e-05	CcSEcCtD
Paroxetine—Musculoskeletal discomfort—Betamethasone—asthma	1.1e-05	7.01e-05	CcSEcCtD
Paroxetine—Arthralgia—Prednisone—asthma	1.1e-05	6.99e-05	CcSEcCtD
Paroxetine—Myalgia—Prednisone—asthma	1.1e-05	6.99e-05	CcSEcCtD
Paroxetine—Feeling abnormal—Triamcinolone—asthma	1.1e-05	6.99e-05	CcSEcCtD
Paroxetine—Feeling abnormal—Methylprednisolone—asthma	1.1e-05	6.97e-05	CcSEcCtD
Paroxetine—Anxiety—Prednisone—asthma	1.09e-05	6.97e-05	CcSEcCtD
Paroxetine—Insomnia—Betamethasone—asthma	1.09e-05	6.96e-05	CcSEcCtD
Paroxetine—Insomnia—Dexamethasone—asthma	1.09e-05	6.96e-05	CcSEcCtD
Paroxetine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—asthma	1.09e-05	6.94e-05	CcSEcCtD
Paroxetine—Gastrointestinal pain—Methylprednisolone—asthma	1.09e-05	6.92e-05	CcSEcCtD
Paroxetine—Paraesthesia—Dexamethasone—asthma	1.09e-05	6.91e-05	CcSEcCtD
Paroxetine—Paraesthesia—Betamethasone—asthma	1.09e-05	6.91e-05	CcSEcCtD
Paroxetine—Discomfort—Prednisone—asthma	1.09e-05	6.91e-05	CcSEcCtD
Paroxetine—Hypersensitivity—Prednisolone—asthma	1.07e-05	6.79e-05	CcSEcCtD
Paroxetine—Dyspepsia—Dexamethasone—asthma	1.06e-05	6.77e-05	CcSEcCtD
Paroxetine—Dyspepsia—Betamethasone—asthma	1.06e-05	6.77e-05	CcSEcCtD
Paroxetine—Urticaria—Triamcinolone—asthma	1.06e-05	6.74e-05	CcSEcCtD
Paroxetine—Urticaria—Methylprednisolone—asthma	1.06e-05	6.72e-05	CcSEcCtD
Paroxetine—Body temperature increased—Triamcinolone—asthma	1.05e-05	6.7e-05	CcSEcCtD
Paroxetine—Oedema—Prednisone—asthma	1.05e-05	6.7e-05	CcSEcCtD
Paroxetine—Anaphylactic shock—Prednisone—asthma	1.05e-05	6.7e-05	CcSEcCtD
Paroxetine—Abdominal pain—Methylprednisolone—asthma	1.05e-05	6.69e-05	CcSEcCtD
Paroxetine—Decreased appetite—Dexamethasone—asthma	1.05e-05	6.69e-05	CcSEcCtD
Paroxetine—Decreased appetite—Betamethasone—asthma	1.05e-05	6.69e-05	CcSEcCtD
Paroxetine—Infection—Prednisone—asthma	1.05e-05	6.66e-05	CcSEcCtD
Paroxetine—Gastrointestinal disorder—Dexamethasone—asthma	1.04e-05	6.64e-05	CcSEcCtD
Paroxetine—Gastrointestinal disorder—Betamethasone—asthma	1.04e-05	6.64e-05	CcSEcCtD
Paroxetine—Hypersensitivity—Hydrocortisone—asthma	1.04e-05	6.64e-05	CcSEcCtD
Paroxetine—Fatigue—Betamethasone—asthma	1.04e-05	6.63e-05	CcSEcCtD
Paroxetine—Fatigue—Dexamethasone—asthma	1.04e-05	6.63e-05	CcSEcCtD
Paroxetine—Shock—Prednisone—asthma	1.04e-05	6.59e-05	CcSEcCtD
Paroxetine—Pain—Dexamethasone—asthma	1.03e-05	6.58e-05	CcSEcCtD
Paroxetine—Pain—Betamethasone—asthma	1.03e-05	6.58e-05	CcSEcCtD
Paroxetine—Nervous system disorder—Prednisone—asthma	1.03e-05	6.57e-05	CcSEcCtD
Paroxetine—Tachycardia—Prednisone—asthma	1.03e-05	6.54e-05	CcSEcCtD
Paroxetine—Skin disorder—Prednisone—asthma	1.02e-05	6.51e-05	CcSEcCtD
Paroxetine—Hyperhidrosis—Prednisone—asthma	1.02e-05	6.48e-05	CcSEcCtD
Paroxetine—Asthenia—Hydrocortisone—asthma	1.02e-05	6.46e-05	CcSEcCtD
Paroxetine—Pruritus—Hydrocortisone—asthma	1e-05	6.37e-05	CcSEcCtD
Paroxetine—Feeling abnormal—Dexamethasone—asthma	9.97e-06	6.34e-05	CcSEcCtD
Paroxetine—Feeling abnormal—Betamethasone—asthma	9.97e-06	6.34e-05	CcSEcCtD
Paroxetine—Gastrointestinal pain—Betamethasone—asthma	9.89e-06	6.29e-05	CcSEcCtD
Paroxetine—Gastrointestinal pain—Dexamethasone—asthma	9.89e-06	6.29e-05	CcSEcCtD
Paroxetine—Hypersensitivity—Triamcinolone—asthma	9.82e-06	6.25e-05	CcSEcCtD
Paroxetine—Hypersensitivity—Methylprednisolone—asthma	9.8e-06	6.23e-05	CcSEcCtD
Paroxetine—Diarrhoea—Hydrocortisone—asthma	9.68e-06	6.16e-05	CcSEcCtD
Paroxetine—Urticaria—Betamethasone—asthma	9.61e-06	6.11e-05	CcSEcCtD
Paroxetine—Urticaria—Dexamethasone—asthma	9.61e-06	6.11e-05	CcSEcCtD
Paroxetine—Musculoskeletal discomfort—Prednisone—asthma	9.59e-06	6.11e-05	CcSEcCtD
Paroxetine—Dizziness—Prednisolone—asthma	9.58e-06	6.1e-05	CcSEcCtD
Paroxetine—Asthenia—Triamcinolone—asthma	9.56e-06	6.08e-05	CcSEcCtD
Paroxetine—Abdominal pain—Betamethasone—asthma	9.56e-06	6.08e-05	CcSEcCtD
Paroxetine—Body temperature increased—Dexamethasone—asthma	9.56e-06	6.08e-05	CcSEcCtD
Paroxetine—Body temperature increased—Betamethasone—asthma	9.56e-06	6.08e-05	CcSEcCtD
Paroxetine—Abdominal pain—Dexamethasone—asthma	9.56e-06	6.08e-05	CcSEcCtD
Paroxetine—Asthenia—Methylprednisolone—asthma	9.54e-06	6.07e-05	CcSEcCtD
Paroxetine—Insomnia—Prednisone—asthma	9.53e-06	6.06e-05	CcSEcCtD
Paroxetine—Paraesthesia—Prednisone—asthma	9.46e-06	6.02e-05	CcSEcCtD
Paroxetine—Pruritus—Triamcinolone—asthma	9.43e-06	6e-05	CcSEcCtD
Paroxetine—Pruritus—Methylprednisolone—asthma	9.41e-06	5.99e-05	CcSEcCtD
Paroxetine—Dizziness—Hydrocortisone—asthma	9.36e-06	5.96e-05	CcSEcCtD
Paroxetine—Dyspepsia—Prednisone—asthma	9.27e-06	5.9e-05	CcSEcCtD
Paroxetine—Decreased appetite—Prednisone—asthma	9.15e-06	5.83e-05	CcSEcCtD
Paroxetine—Rash—Prednisolone—asthma	9.14e-06	5.81e-05	CcSEcCtD
Paroxetine—Dermatitis—Prednisolone—asthma	9.13e-06	5.81e-05	CcSEcCtD
Paroxetine—Diarrhoea—Methylprednisolone—asthma	9.1e-06	5.79e-05	CcSEcCtD
Paroxetine—Fatigue—Prednisone—asthma	9.08e-06	5.78e-05	CcSEcCtD
Paroxetine—Headache—Prednisolone—asthma	9.08e-06	5.78e-05	CcSEcCtD
Paroxetine—Constipation—Prednisone—asthma	9.01e-06	5.73e-05	CcSEcCtD
Paroxetine—Vomiting—Hydrocortisone—asthma	9e-06	5.73e-05	CcSEcCtD
Paroxetine—Rash—Hydrocortisone—asthma	8.92e-06	5.68e-05	CcSEcCtD
Paroxetine—Dermatitis—Hydrocortisone—asthma	8.92e-06	5.67e-05	CcSEcCtD
Paroxetine—Headache—Hydrocortisone—asthma	8.87e-06	5.64e-05	CcSEcCtD
Paroxetine—Dizziness—Triamcinolone—asthma	8.81e-06	5.61e-05	CcSEcCtD
Paroxetine—Dizziness—Methylprednisolone—asthma	8.79e-06	5.6e-05	CcSEcCtD
Paroxetine—Feeling abnormal—Prednisone—asthma	8.68e-06	5.52e-05	CcSEcCtD
Paroxetine—Asthenia—Dexamethasone—asthma	8.68e-06	5.52e-05	CcSEcCtD
Paroxetine—Asthenia—Betamethasone—asthma	8.68e-06	5.52e-05	CcSEcCtD
Paroxetine—Gastrointestinal pain—Prednisone—asthma	8.61e-06	5.48e-05	CcSEcCtD
Paroxetine—Nausea—Prednisolone—asthma	8.61e-06	5.48e-05	CcSEcCtD
Paroxetine—Pruritus—Betamethasone—asthma	8.56e-06	5.44e-05	CcSEcCtD
Paroxetine—Pruritus—Dexamethasone—asthma	8.56e-06	5.44e-05	CcSEcCtD
Paroxetine—Vomiting—Triamcinolone—asthma	8.47e-06	5.39e-05	CcSEcCtD
Paroxetine—Vomiting—Methylprednisolone—asthma	8.46e-06	5.38e-05	CcSEcCtD
Paroxetine—Nausea—Hydrocortisone—asthma	8.41e-06	5.35e-05	CcSEcCtD
Paroxetine—Rash—Triamcinolone—asthma	8.4e-06	5.35e-05	CcSEcCtD
Paroxetine—Dermatitis—Triamcinolone—asthma	8.4e-06	5.34e-05	CcSEcCtD
Paroxetine—Rash—Methylprednisolone—asthma	8.38e-06	5.34e-05	CcSEcCtD
Paroxetine—Dermatitis—Methylprednisolone—asthma	8.38e-06	5.33e-05	CcSEcCtD
Paroxetine—Urticaria—Prednisone—asthma	8.37e-06	5.32e-05	CcSEcCtD
Paroxetine—Headache—Triamcinolone—asthma	8.35e-06	5.31e-05	CcSEcCtD
Paroxetine—Headache—Methylprednisolone—asthma	8.33e-06	5.3e-05	CcSEcCtD
Paroxetine—Body temperature increased—Prednisone—asthma	8.33e-06	5.3e-05	CcSEcCtD
Paroxetine—Abdominal pain—Prednisone—asthma	8.33e-06	5.3e-05	CcSEcCtD
Paroxetine—Diarrhoea—Dexamethasone—asthma	8.27e-06	5.26e-05	CcSEcCtD
Paroxetine—Diarrhoea—Betamethasone—asthma	8.27e-06	5.26e-05	CcSEcCtD
Paroxetine—Dizziness—Dexamethasone—asthma	8e-06	5.09e-05	CcSEcCtD
Paroxetine—Dizziness—Betamethasone—asthma	8e-06	5.09e-05	CcSEcCtD
Paroxetine—Nausea—Triamcinolone—asthma	7.92e-06	5.04e-05	CcSEcCtD
Paroxetine—Nausea—Methylprednisolone—asthma	7.9e-06	5.03e-05	CcSEcCtD
Paroxetine—Hypersensitivity—Prednisone—asthma	7.76e-06	4.94e-05	CcSEcCtD
Paroxetine—Vomiting—Betamethasone—asthma	7.69e-06	4.89e-05	CcSEcCtD
Paroxetine—Vomiting—Dexamethasone—asthma	7.69e-06	4.89e-05	CcSEcCtD
Paroxetine—Rash—Dexamethasone—asthma	7.62e-06	4.85e-05	CcSEcCtD
Paroxetine—Rash—Betamethasone—asthma	7.62e-06	4.85e-05	CcSEcCtD
Paroxetine—Dermatitis—Dexamethasone—asthma	7.62e-06	4.85e-05	CcSEcCtD
Paroxetine—Dermatitis—Betamethasone—asthma	7.62e-06	4.85e-05	CcSEcCtD
Paroxetine—Headache—Betamethasone—asthma	7.58e-06	4.82e-05	CcSEcCtD
Paroxetine—Headache—Dexamethasone—asthma	7.58e-06	4.82e-05	CcSEcCtD
Paroxetine—Asthenia—Prednisone—asthma	7.56e-06	4.81e-05	CcSEcCtD
Paroxetine—Pruritus—Prednisone—asthma	7.45e-06	4.74e-05	CcSEcCtD
Paroxetine—Diarrhoea—Prednisone—asthma	7.21e-06	4.58e-05	CcSEcCtD
Paroxetine—Nausea—Betamethasone—asthma	7.18e-06	4.57e-05	CcSEcCtD
Paroxetine—Nausea—Dexamethasone—asthma	7.18e-06	4.57e-05	CcSEcCtD
Paroxetine—Dizziness—Prednisone—asthma	6.96e-06	4.43e-05	CcSEcCtD
Paroxetine—Vomiting—Prednisone—asthma	6.7e-06	4.26e-05	CcSEcCtD
Paroxetine—Rash—Prednisone—asthma	6.64e-06	4.23e-05	CcSEcCtD
Paroxetine—Dermatitis—Prednisone—asthma	6.63e-06	4.22e-05	CcSEcCtD
Paroxetine—Headache—Prednisone—asthma	6.6e-06	4.2e-05	CcSEcCtD
Paroxetine—Nausea—Prednisone—asthma	6.26e-06	3.98e-05	CcSEcCtD
Paroxetine—CHRM1—Signaling Pathways—ITPR1—asthma	3.21e-06	4.24e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—ITPR1—asthma	3.2e-06	4.22e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling by GPCR—RHOA—asthma	3.18e-06	4.19e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—ITPR1—asthma	3.17e-06	4.18e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling by GPCR—RHOA—asthma	3.16e-06	4.17e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling by GPCR—RHOA—asthma	3.15e-06	4.16e-05	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—POMC—asthma	3.15e-06	4.15e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling by GPCR—RHOA—asthma	3.12e-06	4.12e-05	CbGpPWpGaD
Paroxetine—ABCB1—Transmembrane transport of small molecules—ALB—asthma	3.12e-06	4.12e-05	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—CCL2—asthma	3.08e-06	4.06e-05	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—PLA2G4A—asthma	3.08e-06	4.06e-05	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—GSTM1—asthma	3.08e-06	4.06e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—CD86—asthma	3.08e-06	4.06e-05	CbGpPWpGaD
Paroxetine—HTR2A—GPCR downstream signaling—CXCL8—asthma	3.08e-06	4.05e-05	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—IL6R—asthma	3.07e-06	4.04e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—asthma	3.07e-06	4.04e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—CD86—asthma	3.06e-06	4.03e-05	CbGpPWpGaD
Paroxetine—CHRM1—GPCR downstream signaling—CXCL8—asthma	3.06e-06	4.03e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—EDN1—asthma	3.05e-06	4.02e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—CD86—asthma	3.05e-06	4.02e-05	CbGpPWpGaD
Paroxetine—CHRM3—GPCR downstream signaling—CXCL8—asthma	3.05e-06	4.02e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—EDN1—asthma	3.04e-06	4e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—CCL5—asthma	3.03e-06	3.99e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—EDN1—asthma	3.03e-06	3.99e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—CD86—asthma	3.02e-06	3.98e-05	CbGpPWpGaD
Paroxetine—CHRM2—GPCR downstream signaling—CXCL8—asthma	3.02e-06	3.98e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—PLA2G4A—asthma	3.02e-06	3.98e-05	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—POMC—asthma	3.01e-06	3.97e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—CCL5—asthma	3.01e-06	3.97e-05	CbGpPWpGaD
Paroxetine—CHRM4—Signaling by GPCR—EGFR—asthma	3.01e-06	3.97e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—CCL5—asthma	3e-06	3.96e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—PLA2G4A—asthma	3e-06	3.96e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—EDN1—asthma	3e-06	3.95e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—PLA2G4A—asthma	2.99e-06	3.94e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—CSF2—asthma	2.98e-06	3.93e-05	CbGpPWpGaD
Paroxetine—TACR1—Signaling Pathways—IL6—asthma	2.98e-06	3.92e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—CCL5—asthma	2.97e-06	3.92e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—CSF2—asthma	2.97e-06	3.91e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—PLA2G4A—asthma	2.96e-06	3.9e-05	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—NQO1—asthma	2.96e-06	3.9e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—CSF2—asthma	2.96e-06	3.9e-05	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—CCL2—asthma	2.95e-06	3.88e-05	CbGpPWpGaD
Paroxetine—HTR2A—GPCR downstream signaling—IL2—asthma	2.94e-06	3.87e-05	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—IL6R—asthma	2.94e-06	3.87e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—CSF2—asthma	2.93e-06	3.86e-05	CbGpPWpGaD
Paroxetine—CHRM1—GPCR downstream signaling—IL2—asthma	2.92e-06	3.85e-05	CbGpPWpGaD
Paroxetine—CHRM3—GPCR downstream signaling—IL2—asthma	2.91e-06	3.84e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—SMAD3—asthma	2.9e-06	3.83e-05	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—ADCY2—asthma	2.9e-06	3.82e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—SMAD3—asthma	2.89e-06	3.81e-05	CbGpPWpGaD
Paroxetine—CHRM2—GPCR downstream signaling—IL2—asthma	2.89e-06	3.8e-05	CbGpPWpGaD
Paroxetine—CHRM5—Signaling by GPCR—EGFR—asthma	2.88e-06	3.8e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—SMAD3—asthma	2.88e-06	3.8e-05	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—asthma	2.88e-06	3.79e-05	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—SERPINE1—asthma	2.87e-06	3.79e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—SMAD3—asthma	2.85e-06	3.76e-05	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—GSTP1—asthma	2.84e-06	3.74e-05	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—PPP2CA—asthma	2.83e-06	3.74e-05	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—HMOX1—asthma	2.8e-06	3.69e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling by GPCR—CXCL8—asthma	2.79e-06	3.68e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—NQO1—asthma	2.79e-06	3.68e-05	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—ITPR1—asthma	2.79e-06	3.68e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—PPP2CA—asthma	2.78e-06	3.66e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling by GPCR—CXCL8—asthma	2.78e-06	3.66e-05	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—RHOA—asthma	2.77e-06	3.65e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling by GPCR—CXCL8—asthma	2.77e-06	3.65e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—NQO1—asthma	2.77e-06	3.65e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—PPP2CA—asthma	2.76e-06	3.64e-05	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—CAT—asthma	2.76e-06	3.64e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—PPP2CA—asthma	2.75e-06	3.63e-05	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—SERPINE1—asthma	2.75e-06	3.63e-05	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—NOS3—asthma	2.74e-06	3.62e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling by GPCR—CXCL8—asthma	2.74e-06	3.61e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—ADCY2—asthma	2.73e-06	3.6e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—CCR5—asthma	2.73e-06	3.6e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—PPP2CA—asthma	2.73e-06	3.6e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—CCR5—asthma	2.71e-06	3.58e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—ADCY2—asthma	2.71e-06	3.57e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—CCR5—asthma	2.71e-06	3.57e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—IL2RA—asthma	2.69e-06	3.54e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—asthma	2.68e-06	3.54e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—CCR5—asthma	2.68e-06	3.53e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—IL2RA—asthma	2.67e-06	3.53e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling by GPCR—IL2—asthma	2.67e-06	3.52e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—C3—asthma	2.67e-06	3.51e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—IL2RA—asthma	2.67e-06	3.51e-05	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—RHOA—asthma	2.65e-06	3.5e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling by GPCR—IL2—asthma	2.65e-06	3.5e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—C3—asthma	2.65e-06	3.5e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling by GPCR—IL2—asthma	2.65e-06	3.49e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—C3—asthma	2.64e-06	3.48e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—IL2RA—asthma	2.64e-06	3.48e-05	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—NOS3—asthma	2.63e-06	3.46e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling by GPCR—IL2—asthma	2.62e-06	3.45e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—C3—asthma	2.62e-06	3.45e-05	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—PLA2G4A—asthma	2.61e-06	3.43e-05	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—GSTM1—asthma	2.61e-06	3.43e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—PDGFB—asthma	2.6e-06	3.42e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—PDGFB—asthma	2.58e-06	3.4e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—PDGFB—asthma	2.57e-06	3.39e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—PDGFB—asthma	2.55e-06	3.36e-05	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—POMC—asthma	2.53e-06	3.33e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—LEP—asthma	2.48e-06	3.27e-05	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—GSTP1—asthma	2.47e-06	3.26e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—LEP—asthma	2.47e-06	3.25e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—LEP—asthma	2.46e-06	3.24e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—LEP—asthma	2.44e-06	3.21e-05	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—HMOX1—asthma	2.44e-06	3.21e-05	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—CXCL8—asthma	2.43e-06	3.21e-05	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—ITPR1—asthma	2.43e-06	3.2e-05	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—CAT—asthma	2.4e-06	3.17e-05	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—PPP2CA—asthma	2.4e-06	3.16e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—asthma	2.34e-06	3.09e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—FN1—asthma	2.34e-06	3.09e-05	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—CXCL8—asthma	2.33e-06	3.07e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—FN1—asthma	2.33e-06	3.07e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—GSTP1—asthma	2.33e-06	3.07e-05	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—IL2—asthma	2.33e-06	3.07e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—FN1—asthma	2.32e-06	3.06e-05	CbGpPWpGaD
Paroxetine—CHRM4—Signaling by GPCR—IL6—asthma	2.31e-06	3.05e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—GSTP1—asthma	2.31e-06	3.04e-05	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—ALB—asthma	2.31e-06	3.04e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—FN1—asthma	2.3e-06	3.03e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—HMOX1—asthma	2.3e-06	3.03e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—ITPR1—asthma	2.29e-06	3.02e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—HMOX1—asthma	2.28e-06	3e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—ITPR1—asthma	2.27e-06	2.99e-05	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—PLA2G4A—asthma	2.27e-06	2.99e-05	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—GSTM1—asthma	2.27e-06	2.99e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—CAT—asthma	2.27e-06	2.99e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—CAT—asthma	2.25e-06	2.96e-05	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—IL2—asthma	2.23e-06	2.94e-05	CbGpPWpGaD
Paroxetine—CHRM5—Signaling by GPCR—IL6—asthma	2.22e-06	2.92e-05	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—NOS3—asthma	2.21e-06	2.91e-05	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—MMP9—asthma	2.2e-06	2.9e-05	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—PTEN—asthma	2.19e-06	2.88e-05	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—POMC—asthma	2.18e-06	2.87e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—PLA2G4A—asthma	2.14e-06	2.82e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—GSTM1—asthma	2.14e-06	2.82e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—POMC—asthma	2.13e-06	2.81e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—POMC—asthma	2.12e-06	2.8e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—GSTM1—asthma	2.12e-06	2.8e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—PLA2G4A—asthma	2.12e-06	2.8e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—POMC—asthma	2.11e-06	2.79e-05	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—MMP9—asthma	2.11e-06	2.78e-05	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—PTEN—asthma	2.1e-06	2.76e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—POMC—asthma	2.09e-06	2.76e-05	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—PPP2CA—asthma	2.09e-06	2.76e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—CCL2—asthma	2.09e-06	2.75e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—IL6R—asthma	2.08e-06	2.74e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—CCL2—asthma	2.08e-06	2.74e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—IL6R—asthma	2.07e-06	2.73e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—CCL2—asthma	2.07e-06	2.73e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—IL6R—asthma	2.06e-06	2.72e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—CCL2—asthma	2.05e-06	2.7e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—IL6R—asthma	2.04e-06	2.69e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling by GPCR—EGFR—asthma	2.04e-06	2.69e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling by GPCR—EGFR—asthma	2.03e-06	2.68e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling by GPCR—EGFR—asthma	2.02e-06	2.67e-05	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—PTGS2—asthma	2.02e-06	2.66e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling by GPCR—EGFR—asthma	2e-06	2.64e-05	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—ALB—asthma	1.98e-06	2.61e-05	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—VEGFA—asthma	1.98e-06	2.61e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—PPP2CA—asthma	1.97e-06	2.6e-05	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—STAT3—asthma	1.96e-06	2.58e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—PPP2CA—asthma	1.95e-06	2.57e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—SERPINE1—asthma	1.95e-06	2.57e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—SERPINE1—asthma	1.94e-06	2.55e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—SERPINE1—asthma	1.93e-06	2.55e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—SERPINE1—asthma	1.91e-06	2.52e-05	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—NOS3—asthma	1.9e-06	2.5e-05	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—VEGFA—asthma	1.89e-06	2.49e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—RHOA—asthma	1.88e-06	2.48e-05	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—STAT3—asthma	1.87e-06	2.47e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—RHOA—asthma	1.87e-06	2.46e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—RHOA—asthma	1.86e-06	2.46e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—NOS3—asthma	1.86e-06	2.45e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—NOS3—asthma	1.85e-06	2.44e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—RHOA—asthma	1.85e-06	2.43e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—NOS3—asthma	1.84e-06	2.43e-05	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—POMC—asthma	1.84e-06	2.43e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—NOS3—asthma	1.83e-06	2.41e-05	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—TGFB1—asthma	1.81e-06	2.39e-05	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—EGFR—asthma	1.78e-06	2.34e-05	CbGpPWpGaD
Paroxetine—CHRM3—Metabolism—PTEN—asthma	1.76e-06	2.32e-05	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—TGFB1—asthma	1.74e-06	2.29e-05	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—PTGS2—asthma	1.74e-06	2.29e-05	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—EGFR—asthma	1.7e-06	2.24e-05	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—ALB—asthma	1.68e-06	2.21e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—CXCL8—asthma	1.65e-06	2.17e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—CXCL8—asthma	1.64e-06	2.16e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—CXCL8—asthma	1.64e-06	2.16e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—CXCL8—asthma	1.62e-06	2.13e-05	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—NOS3—asthma	1.61e-06	2.12e-05	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—POMC—asthma	1.6e-06	2.11e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—IL2—asthma	1.58e-06	2.08e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling by GPCR—IL6—asthma	1.57e-06	2.07e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—IL2—asthma	1.57e-06	2.07e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—IL2—asthma	1.56e-06	2.06e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling by GPCR—IL6—asthma	1.56e-06	2.06e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling by GPCR—IL6—asthma	1.56e-06	2.05e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—IL2—asthma	1.55e-06	2.04e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling by GPCR—IL6—asthma	1.54e-06	2.03e-05	CbGpPWpGaD
Paroxetine—CYP2B6—Metabolism—PTEN—asthma	1.51e-06	1.99e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—POMC—asthma	1.51e-06	1.99e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—POMC—asthma	1.5e-06	1.98e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—MMP9—asthma	1.49e-06	1.97e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—MMP9—asthma	1.48e-06	1.96e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—PTEN—asthma	1.48e-06	1.96e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—MMP9—asthma	1.48e-06	1.95e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—PTEN—asthma	1.48e-06	1.94e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—PTEN—asthma	1.47e-06	1.94e-05	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—PTGS2—asthma	1.47e-06	1.94e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—MMP9—asthma	1.47e-06	1.93e-05	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—ALB—asthma	1.46e-06	1.93e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—PTEN—asthma	1.46e-06	1.92e-05	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—NOS3—asthma	1.4e-06	1.84e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—ALB—asthma	1.38e-06	1.82e-05	CbGpPWpGaD
Paroxetine—CHRM4—Signaling Pathways—IL6—asthma	1.37e-06	1.8e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—ALB—asthma	1.37e-06	1.8e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—VEGFA—asthma	1.34e-06	1.77e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—VEGFA—asthma	1.33e-06	1.76e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—VEGFA—asthma	1.33e-06	1.75e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—STAT3—asthma	1.33e-06	1.75e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—STAT3—asthma	1.32e-06	1.74e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—NOS3—asthma	1.32e-06	1.74e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—VEGFA—asthma	1.32e-06	1.73e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—STAT3—asthma	1.32e-06	1.73e-05	CbGpPWpGaD
Paroxetine—CHRM5—Signaling Pathways—IL6—asthma	1.31e-06	1.73e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—NOS3—asthma	1.31e-06	1.72e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—STAT3—asthma	1.3e-06	1.72e-05	CbGpPWpGaD
Paroxetine—CYP2C8—Metabolism—PTEN—asthma	1.28e-06	1.69e-05	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—PTGS2—asthma	1.28e-06	1.69e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—TGFB1—asthma	1.23e-06	1.62e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—TGFB1—asthma	1.22e-06	1.61e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—TGFB1—asthma	1.22e-06	1.61e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—TGFB1—asthma	1.21e-06	1.59e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—PTGS2—asthma	1.21e-06	1.59e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—EGFR—asthma	1.21e-06	1.59e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—EGFR—asthma	1.2e-06	1.58e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—PTGS2—asthma	1.2e-06	1.58e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—EGFR—asthma	1.2e-06	1.58e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—EGFR—asthma	1.18e-06	1.56e-05	CbGpPWpGaD
Paroxetine—ABCB1—Metabolism—PTEN—asthma	1.12e-06	1.47e-05	CbGpPWpGaD
Paroxetine—CYP2D6—Metabolism—PTEN—asthma	1.05e-06	1.39e-05	CbGpPWpGaD
Paroxetine—CYP2C9—Metabolism—PTEN—asthma	1.04e-06	1.37e-05	CbGpPWpGaD
Paroxetine—HTR2A—Signaling Pathways—IL6—asthma	9.27e-07	1.22e-05	CbGpPWpGaD
Paroxetine—CHRM1—Signaling Pathways—IL6—asthma	9.22e-07	1.21e-05	CbGpPWpGaD
Paroxetine—CHRM3—Signaling Pathways—IL6—asthma	9.19e-07	1.21e-05	CbGpPWpGaD
Paroxetine—CHRM2—Signaling Pathways—IL6—asthma	9.1e-07	1.2e-05	CbGpPWpGaD
